Taiwan’s leader of precision medicine on the international market: the eighth anniversary of the establishment of the China Medical University and Medical System “Multidimensional Printing Medical Research and Translation Center”
(Central News Agency Information Service 20220915 10:58:11) China Medical University, medical system and international cooperation established the eighth anniversary of the “Multidimensional Printing Medical Research and Translation Center”, Fang Xinyuan, Vice President of the Department of Surgery of the Chinese medicine affiliate and director of the center, celebrated the tea party on the 14th. It is hoped that the team will advance towards high-end regenerative medicine technology, precision drug screening and next-generation exosome drug development in future, find more effective treatment methods for acute and critically ill patients and lead Taiwan’s precision medicine around the world.
China Medical University and its affiliated hospitals have solid research energy and huge medical resources Considering that forward-thinking and cutting-edge technology is widely used in the medical field of various diseases, it is a medical development trend with unlimited business opportunities in the future International cooperation to create China’s first 3D printing medical research and development center. Over the past eight years, with the assistance of Professor Wang Xubin of Georgia Institute of Technology and the integration of Vice President Fang Xinyuan, a cross-clinical and research team has been formed to realize the commercialization of innovative 3D medical technologies and equipment, and promote it to clinical applications in orthopedics, dentistry. The development of innovative medical materials in trauma medicine, cancer medicine and surgical applications has benefited thousands of patients in the medical system.
Vice President Fang Xinyuan said with satisfaction that, in addition to clinical application, the center’s technological innovation has also produced a fruitful and dazzling transcript. At the same time, he published 120 articles in leading international SCI journals and obtained 30 domestic and foreign patents, and also helped in the creation of new companies and in the development of multisectoral cooperation technologies; the accumulation of these technological developments has also allowed the team to win the recognition of the National Award for Innovation for 4 consecutive years and also win the Future Technology Award of the Ministry of Science and Technology in 2021.
More importantly, the accumulated experience in clinical product research and development has been gradually extended to Taiwan medical institutions, benefiting Taiwanese patients who need to use these various innovative technologies and medical materials, and improving health and welfare of our country. and national health.
Professor Chen Yiwen, Deputy Director of the “Multidimensional Printing Medical Research and Translation Center”, said that the application of cutting-edge and cutting-edge technologies in the medical field of various diseases is a medical development trend with unlimited business opportunities in future The progress of 3D printing technology conforms to this wave Under the trend, the clinical application has undergone revolutionary changes.
As a new tool for precision regenerative medicine, 3D bioprinting is an indispensable element in this wave of future medical trends. Deputy Director Chen Yiwen said the team is well aware of the importance of selecting topics for medical technology domains and applications. . Our key development will include regenerative medicine biological matrix creation, organoid drug screening technology platform, exosome mass production technology, nanocarrier surface modification and biosensing and other directions, cross-domain chain, cross-industry and cross-border In this way, there is an opportunity to develop effective treatment.
With the full support of President Cai Changhai, President Hong Mingqi and President Zhou Deyang, the “Multidimensional Printing Medical Research and Translation Center”, renamed in 2020, has shifted its development goal towards creating a medical technology platform of high-end, and focused on integrating its technology For commercialization and translation for clinical application, Associate Hospital Fang Xinyuan promises an eight-year long-term commitment. We will make concerted efforts to help Taiwan’s precision medicine go international and open a new page.
–
